Haleon (HLNCF) Total Current Liabilities (2021 - 2025)
Haleon (HLNCF) recorded quarterly Total Current Liabilities of $6.6 billion in Q4 2025, down 12.04% on a QoQ basis from $7.5 billion in Q4 2024, and down 12.04% year-over-year from $7.5 billion in Q4 2024.
Haleon (HLNCF) Total Current Liabilities (2021 - 2025) Analysis & Trends
Haleon has disclosed Total Current Liabilities across 5 years of filings, most recently posting $6.6 billion for Q4 2025.
- Quarterly Total Current Liabilities fell 12.04% year-over-year to $6.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.6 billion (down 12.04% YoY) and the FY2025 annual result came in at $6.5 billion, down 12.45% from the prior year.
- Total Current Liabilities retreated to $6.6 billion in Q4 2025, from $7.5 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $7.5 billion in Q4 2024 and troughed at -$7.1 billion in Q2 2024.
- A 5-year average of $1.5 billion and a median of $5.4 billion in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities dropped 18.02% — and 2024, when it grew 29.53%.
- Tracing HLNCF's Total Current Liabilities over 5 years: stood at $5.7 billion in 2021, then decreased by 10.28% to $5.1 billion in 2022, then grew by 12.35% to $5.8 billion in 2023, then climbed by 29.53% to $7.5 billion in 2024, then dropped by 12.04% to $6.6 billion in 2025.
- Business Quant data shows HLNCF's Total Current Liabilities at $6.6 billion in Q4 2025, $7.5 billion in Q4 2024, and -$7.1 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Haleon | - | - | - | 6.56 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.56 Bn |
| Dec 31, 2024 | 7.46 Bn |
| Jun 30, 2024 | -7.10 Bn |
| Dec 31, 2023 | 5.76 Bn |
| Jun 30, 2023 | -6.24 Bn |
| Dec 31, 2022 | 5.13 Bn |
| Jun 30, 2022 | -5.29 Bn |
| Dec 31, 2021 | 5.71 Bn |